Guggenheim Capital’s General Moly, Inc. GMO Stock Holding History

Guggenheim Capital’s Portfolio GMO Stock Details GMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-19,909	Closed	-$8K	–	2715
2018 Q1	$8K	Buy	19,909 +121	+0.6%	+$47	﹤0.01%	2768
2017 Q4	$7K	Sell	19,788 -2,471	-11%	-$787	﹤0.01%	2697
2017 Q3	$8K	Buy	22,259 +4,151	+23%	+$1.75K	﹤0.01%	2787
2017 Q2	$7K	Hold	18,108	–	–	﹤0.01%	2819
2017 Q1	$9K	Buy	+18,108	New	+$8.71K	﹤0.01%	2821
2016 Q3	–	Sell	-34,034	Closed	-$12K	–	2937
2016 Q2	$12K	Hold	34,034	–	–	﹤0.01%	2841
2016 Q1	$12K	Buy	34,034 +7,334	+27%	+$1.75K	﹤0.01%	2865
2015 Q4	$5K	Buy	+26,700	New	+$7.28K	﹤0.01%	2965
2015 Q1	–	Sell	-14,555	Closed	-$8K	–	3095
2014 Q4	$8K	Buy	+14,555	New	+$8.2K	﹤0.01%	2997
2014 Q3	–	Sell	-30,396	Closed	-$35K	–	3173
2014 Q2	$35K	Sell	30,396 -1,748	-5%	-$1.82K	﹤0.01%	3117
2014 Q1	$32K	Buy	+32,144	New	+$39K	﹤0.01%	3186
2013 Q4	–	Sell	-15,080	Closed	-$25K	–	3290
2013 Q3	$25K	Buy	15,080 +4,684	+45%	+$8.45K	﹤0.01%	3005
2013 Q2	$19K	Buy	+10,396	New	+$20.5K	﹤0.01%	2991

Other funds holding GMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Evanston Advisors Schaumburg, Illinois $368M AUM 7.83% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

SIM

Sonora Investment Management Tucson, Arizona $798M AUM 17.61% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Guggenheim Capital's GMO Position: Q2 2018 in Review

Guggenheim Capital sold out of General Moly, Inc. (GMO) in Q2 2018, closing a stake of 19,909 shares — an estimated $8K sold.

Guggenheim Capital first reported a position in GMO in Q2 2013 and held it in 13 quarters. The position peaked at $35K in Q2 2014. 41 funds tracked by Wall St. Rank hold GMO as of Q2 2018.

Guggenheim Capital reported no remaining General Moly, Inc. position as of Q2 2018 after selling out during the quarter.
Guggenheim Capital sold 19,909 General Moly, Inc. shares in Q2 2018, an estimated $8K.
Guggenheim Capital first reported a position in General Moly, Inc. in Q2 2013 and held it in 13 quarters.
Guggenheim Capital's General Moly, Inc. position peaked at $35K in Q2 2014.
41 funds tracked by Wall St. Rank held General Moly, Inc. as of Q2 2018.

Based on Guggenheim Capital's 13F filing for Q2 2018, filed 14 Aug 2018.